Archive for July, 2010

Anadys Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5, 2010 at 1:15 p.m. EDT (10:15 a.m. PDT).  The conference is being held at...

Chairman Ed Towns Earns the ‘Spirit of Independence Award’ from National Industries for the Blind

Coinciding with the 20th Anniversary of the Americans with Disabilities Act Economic and Personal Independence for People Who are Blind WASHINGTON, July 30 /PRNewswire-USNewswire/ -- Chairman Edolphus (Ed) Towns (D-10th-New York), a long-time AbilityOne Champion, has earned the "Spirit of...

Bill Tella, Specialty Pharmacy Executive, Joins DW Healthcare Partners’ Executive in Residence Program

PARK CITY, Utah, July 30 /PRNewswire/ -- DW Healthcare Partners (DWHP), a healthcare focused private equity firm with over $250 million in committed capital under management, today announced that Mr. William Tella, former President of Curative Specialty Pharmacy, will join DWHP's Executive in...

Camille Johnston Joins Siemens in the U.S. as Vice President, Corporate Affairs

NEW YORK, July 30 /PRNewswire-FirstCall/ -- Siemens Corporation today announced that Camille Johnston will join the company as Vice President, Corporate Affairs, effective September 7.  In this position, she will be a member of the U.S. leadership team and will be responsible for...

Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma

ALLEGAN, Mich., July 30 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical...

FDA Approves Vaccines for the 2010-2011 Influenza Season

SILVER SPRING, Md., July 30 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo:...

CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN) today announced plans to release fourth quarter and fiscal 2010 results on Tuesday, Aug. 10 following the close of trading on the New York Stock Exchange. The company will host a webcast and conference call on Aug. 10...

European Union Approves Maize with Herculex® I/Herculex® RW and Herculex® RW/ Herculex® I/Roundup Ready® Corn 2 Trait Stacks for Import, Food, Feed & Processing

BRUSSELS, July 30 /PRNewswire-FirstCall/ --  The European Commission announced that it has granted import, food, feed and processing approvals for biotechnology maize products jointly developed by DuPont (NYSE: DD) business Pioneer Hi-Bred and Dow AgroSciences LLC, a wholly owned subsidiary of...

Mylan Announces Pricing of Add-On Offering of Senior Notes

PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that it priced $300 million aggregate principal amount of Senior Notes due 2020 at an issue price of 105.5% with a coupon of 7.875%, or an effective yield to maturity of 7.087%. The notes are being offered as...

Fred Hutchinson Cancer Research Center Announces Selection of Its New President and Director

SEATTLE, July 30 /PRNewswire/ -- The Fred Hutchinson Cancer Research Center board of trustees today announced the selection of Lawrence Corey, M.D., an internationally renowned expert in virology, immunology and vaccine development, as its new president and director. He is expected to begin...
Get Adobe Flash playerPlugin by wpburn.com wordpress themes